Obesity
Showing NaN - NaN of 97
The Living With a Long-Term Condition Study
Recruiting
- Asthma
- +44 more
- Living with LTC Questionnaire
-
London, United KingdomKing's College London
Oct 10, 2023
Eating Behavior, Obesity, Appetitive Behavior Trial in London (0 kcal liquid, 600 kcal liquid meal, 1200 kcal liquid meal)
Recruiting
- Eating Behavior
- +2 more
- 0 kcal liquid
- +3 more
-
London, United KingdomPsychoNeuroEndocrinology Research Group, Division of Psychiatry,
Aug 29, 2023
Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Obesity
- Cardiovascular Diseases
- Retatrutide
- Placebo
-
Phoenix, Arizona
- +165 more
May 22, 2023
Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
Recruiting
- Obesity
- +4 more
- Observational
-
London, United KingdomChelsea & Westminster Hospital Nhs Ft
Mar 1, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())
Active, not recruiting
- Obesity
- semaglutide 2.4 mg
- semaglutide 2.4 mg (placebo)
-
Montgomery, Alabama
- +64 more
Jan 24, 2023
HIV Nephropathy, Kidney Injury, Kidney Diseases Trial in London
Active, not recruiting
- HIV Nephropathy
- +6 more
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Jan 5, 2023
Obesity, Overweight and Obesity Trial in London (B. breve, Placebo)
Recruiting
- Obesity
- Overweight and Obesity
- B. breve
- Placebo
-
London, Ontario, CanadaKGK Science Inc
Jan 9, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity, Cardiometabolic Syndrome, Overweight Trial in London (Healthy, balanced Diet A, Healthy, balanced Diet B, Behavioural
Not yet recruiting
- Obesity
- +2 more
- Healthy, balanced Diet A
- +2 more
-
London, United KingdomUCL
Nov 23, 2022
Obesity, Diabetes, Metabolic Syndrome Trial in London (Semaglutide 3 mg, Placebo)
Recruiting
- Obesity
- +2 more
- Semaglutide 3 mg
- Placebo
-
London, United KingdomUCL
Nov 3, 2022
Obesity, Body Image Disorder, Bariatric Surgery Candidate Trial in London (Virtual Reality and 3D Reconstruction)
Recruiting
- Obesity
- +2 more
- Virtual Reality and 3D Reconstruction
-
London, United KingdomSt Mary's Hospital
Sep 14, 2022
Bariatric Surgery Candidate, Obesity Trial in London (Online exercise intervention)
Enrolling by invitation
- Bariatric Surgery Candidate
- Obesity
- Online exercise intervention
-
London, United KingdomUniversity College London
Sep 9, 2022
Periodontal Assessment of a Bariatric Care Population
Active, not recruiting
- Bariatric Surgery Candidate
- Obesity
-
London, United Kingdom
- +1 more
Sep 12, 2022
Who Will Benefit From Bariatric Surgery for Diabetes?
Recruiting
- Diabetes Mellitus, Type 2
- Obesity
- Roux-en-Y gastric bypass (RYGB)
-
London, Greater London, United KingdomImperial College Healthcare NHS Trust
Aug 16, 2022
Diabetes, Heart Diseases, Diet Habit Trial in Needham, London (Dietary Intervention)
Recruiting
- Diabetes
- +7 more
- Dietary Intervention
-
Needham, Massachusetts
- +1 more
Jul 9, 2022
Obesity Trial in London (modified media content paradigm, control)
Recruiting
- Obesity
- modified media content paradigm
- control
-
London, United KingdomUniversity College London Hospital
May 16, 2022
Obesity Trial in Worldwide (Semaglutide 2.4 mg, Placebo)
Active, not recruiting
- Obesity
- Semaglutide 2.4 mg
- Placebo
-
Calgary, Alberta, Canada
- +21 more
Mar 22, 2022
Obesity Trial in London (Maltodextrin (carbohydrate), Exercise, Rest)
Completed
- Obesity
- Maltodextrin (carbohydrate)
- +3 more
-
London, United KingdomImperial Clinical Research Facility
Feb 16, 2022